Explore

Trendline Trendline
Inhibrx Biosciences Reports Financial Results Amid Ongoing Clinical Trials

Inhibrx Biosciences Reports Financial Results Amid Ongoing Clinical Trials

Inhibrx Biosciences Reports Financial Results Amid Ongoing Clinical Trials
Trendline Trendline
Inhibrx Reports Financial Results and Clinical Trial Updates for Q1 2026

Inhibrx Reports Financial Results and Clinical Trial Updates for Q1 2026

Inhibrx Reports Financial Results and Clinical Trial Updates for Q1 2026
Trendline Trendline
Spruce Biosciences Reports Q1 2026 Financial Results and Corporate Updates

Spruce Biosciences Reports Q1 2026 Financial Results and Corporate Updates

Spruce Biosciences Reports Q1 2026 Financial Results and Corporate Updates
Trendline Trendline
Longeveron Reports Q1 Financial Results and Business Developments

Longeveron Reports Q1 Financial Results and Business Developments

Longeveron Reports Q1 Financial Results and Business Developments
Trendline Trendline
Nanoviricides Reports Third Quarter Loss Amid Clinical Advancements

Nanoviricides Reports Third Quarter Loss Amid Clinical Advancements

Nanoviricides Reports Third Quarter Loss Amid Clinical Advancements
Trendline Trendline
BrainStorm Cell Therapeutics Prepares for Phase 3 ALS Study Amid Financial Challenges

BrainStorm Cell Therapeutics Prepares for Phase 3 ALS Study Amid Financial Challenges

BrainStorm Cell Therapeutics Prepares for Phase 3 ALS Study Amid Financial Challenges
Trendline Trendline
Marker Therapeutics Reports Improved Financials Amidst Ongoing Clinical Developments

Marker Therapeutics Reports Improved Financials Amidst Ongoing Clinical Developments

Marker Therapeutics Reports Improved Financials Amidst Ongoing Clinical Developments
Trendline Trendline
Spruce Biosciences Strengthens Financial Position Ahead of Potential U.S. Launch of TA-ERT

Spruce Biosciences Strengthens Financial Position Ahead of Potential U.S. Launch of TA-ERT

Spruce Biosciences Strengthens Financial Position Ahead of Potential U.S. Launch of TA-ERT
Trendline Trendline
Palatin Technologies Reports Q3 2026 Financial Results and Business Progress

Palatin Technologies Reports Q3 2026 Financial Results and Business Progress

Palatin Technologies Reports Q3 2026 Financial Results and Business Progress
Trendline Trendline
Longeveron Reports Q1 Financial Results and Strategic Updates

Longeveron Reports Q1 Financial Results and Strategic Updates

Longeveron Reports Q1 Financial Results and Strategic Updates
Trendline Trendline
Longeveron Reports Q1 2026 Financial Results and Strategic Developments in Stem Cell Therapy

Longeveron Reports Q1 2026 Financial Results and Strategic Developments in Stem Cell Therapy

Longeveron Reports Q1 2026 Financial Results and Strategic Developments in Stem Cell Therapy
Trendline Trendline
Palatin Technologies Reports Q3 2026 Financial Results and Business Update

Palatin Technologies Reports Q3 2026 Financial Results and Business Update

Palatin Technologies Reports Q3 2026 Financial Results and Business Update